Search

  • Search


    REQUEST FOR INFORMATION: SPRI Beads

    HUS-yhtymä

    REQUEST FOR INFORMATION: SPRI Beads

    1. Planning notice published

      Aug 18, 2:29 AMAugust 18, 2026 2:29 AM
    2. Planned competition start

      Nov 1, 12:00 AMNovember 1, 2026 12:00 AM

    Brief

    Finland: Tenders/HUS-yhtymä/REQUEST FOR INFORMATION: SPRI Beads
    Brief

    Medisinsk og laboratorieutstyr

    HUS-yhtymä is planning the procurement of DNA size selection reagents based on paramagnetic beads, utilizing SPRI technology for selective binding and purification of DNA fragments, to be used in next-generation sequencing (NGS) library preparation. Suppliers can provide feedback and input by submitting a response via email to kilpailutus.diagnostiikka@hus.fi, addressing all requirements, providing requested information and documentation, and identifying any concerns or proposed amendments to the draft agreement.

    About the bid

      With this request for information, HUS launches a market consultation to prepare a procurement. The aim of this prior information notice is to find suppliers operating in this field of business, get information of the solutions available in the market, and inform our plans and requirements for the forthcoming procurement. HUS Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center is a SFS-EN ISO 15189:2022 accredited laboratory providing diagnostic and follow-up genetic testing services to all patients at Helsinki University Hospital area. The requested product is expected to be a DNA size selection reagent based on paramagnetic beads suitable for next generation sequencing (NGS) library preparation. It should utilize SPRI technology (Solid Phase Reversible Immobilization) for selective binding and purification of DNA fragments and enable the purification of sequencing libraries using magnetic separation. The estimated annual consumption of the reagent is approximately 2 litres. This estimate is provided for information purposes only and does not constitute a commitment to purchase any specific quantity. Intended Use: The intended use of the product is preparation and purification of NGS libraries compatible with Illumina and Ion Torrent sequencing instruments. Requirements: HUS is interested in products meeting the following requirements related to NGS workflows: 1. The reagent should enable efficient purification of NGS libraries within 150–1000 bp range. 2. The reagent should be compatible with the following NGS library preparation methods: - Ion AmpliSeq Library Kit 2.0 or newer - Ion AmpliSeq HD Library Kit - FusionPlex Reagents for Ion Torrent - Watchmaker DNA Library Prep with Fragmentation - Watchmaker RNA Library Prep Kit with Polaris Depletion 3. The magnetic separation should be efficient, allowing the separation of the beads and supernatant 2 minutes after placing onto the magnetic rack. 4. The reagent should be suitable for both manual and automated NGS workflows. 5. It should efficiently remove smaller DNA fragments, e.g. free adapters and adapter dimers, producing high-quality sequencing libraries as evaluated by fragment analysis and NGS quality metrics. 6. Library purification and yield should be highly repeatable across replicates and reagent lots. The Laboratory of Genetics will assess the performance of each lot. 7. The reagent’s performance should be in line with the SPRI beads currently in use in the laboratory. 8. HUS is interested in package sizes between 50 and 200 ml. 9. Respondents are requested to provide preliminary pricing information (EUR, VAT 0%) and indicative delivery times for the proposed products and/or solution. 10. Respondents are requested to provide the following information and documentation, if available: - Datasheet, Instructions for Use, Certificate of Analysis - Guidelines for optimizing size selection for specific NGS applications - Description of lot-to-lot quality control processes INSTRUCTIONS FOR ANSWERING We kindly request that respondents clearly address all requirements set out in sections 1–8, describe how each requirement is met, provide, to the extent possible, the information and documentation requested under sections 9 and 10, and identify and comment on any concerns, deviations, or proposed amendments to the attached draft agreement for the purchase of goods and its appendices. Respondents are also requested to provide the name and email address of a contact person for any subsequent one-to-one market dialogue and/or requests for additional information from the contracting authority. Please submit your response to this request for information by email to kilpailutus.diagnostiikka@hus.fi no later than 7 September 2026. The subject line of the email must include: HUS 370-2026 SPRI Beads

      Contact name
      Diagnostiikka
      Contact phone
      +358 94711
      Contact email
      kilpailutus.diagnostiikka@hus.fi
      Address
      PL 445 (Uutistie 5, 01770 Vantaa), 00029 HUS

    Custom Assessment Criteria

    Start a free trial to ask your own questions about the tender and get AI-generated answers.

    Award Criteria

      Found no award criteria in the contract notice.

    Qualification requirements

      Found no qualification requirements in the contract notice.

    Previous Contract Winners

    Start a free trial to see who has won similar tenders for this buyer.

    See the full notice

    Contracting authority
    HUS-yhtymä
    Title
    REQUEST FOR INFORMATION: SPRI Beads
    Type
    Planning
    Main code
    33000000Medical equipments, pharmaceuticals and personal care products
    Supplemental codes
    33696000Reagents and contrast media33696500Laboratory reagents
    Location
    Helsinki-Uusimaa

    Active similar competitions

    • HUS-yhtymä

      Laboratorie-kits og reagenser

      Automaattinen nukleiinihappojen eristyslaite

      HUS-yhtymä suunnittelee automaattisen nukleiinihappojen eristyslaitteen hankintaa HUS Diagnostiikkakeskuksen Kliinisen mikrobiologian nukleiinihappoanalytiikkaan, sisältäen laitteen, varalaitteen tai kaksi erillistä eristysmoduulia sekä tarvittavat reagenssit ja tarvikkeet. Hankittavalla laitteella on tarkoitus eristää bakteeri-DNA:ta useista eri näytemateriaaleista, ja eristetyn tuotteen tulee olla validoitu bakteerien 16S-geenin PCR-monistamiseen Sanger-sekvensoinnilla. Toimittajia pyydetään tutustumaan liitteenä oleviin kysymyksiin ja toimittamaan vastaukset sähköpostitse osoitteeseen kilpailutus.diagnostiikka@hus.fi. bioMérieux Suomi OY:llä on todennäköisesti sopimus tällä hetkellä.

      PlanningSep 16, 2026
      Jan 16, 2027(98 days)
    • HUS-yhtymä

      Farmasøytisk engroshandel

      Request For Information – Supply of Boronophenylalanine for pharmaceutical preparation of compound for BNCT treatment

      HUS Group, the joint authority for Helsinki and Uusimaa, is planning the procurement of L-4-boronophenylalanine (BPA) for the pharmaceutical preparation of a compound used in BNCT treatment. Suppliers are asked to provide information on order size, delivery time, shelf-life, quality assurance, and regulatory requirements, and can send questions to HUS Pharmacy to arrange an active discussion.

      PlanningSep 2, 2026
    • HUS-yhtymä

      Medisinsk og laboratorieutstyr

      Request for information: Radioactive seeds (I-125) and plaques (Ru-106) used in eye brachytherapy

      HUS Group is planning the procurement of radioactive products, specifically Iodine-125 (I-125) brachytherapy seeds and Ruthenium-106 (Ru-106) eye plaques/applicators, along with related accessories for the treatment of epibulbar and intraocular tumors. Suppliers are asked to provide information on their product portfolios, typical delivery times, and available options for accessories, quality assurance, and treatment planning systems by submitting their responses via email to kilpailutus.tiimi@hus.fi. Eckert & Ziegler BEBIG GmbH likely has the contract today.

      PlanningOct 5, 2026
      Jan 25, 2027(107 days)
    • Sansia Oy

      Medisinsk og laboratorieutstyr

      TIETOPYYNTÖ Mikrobiologian nukleiinihappo-osoitusmenetelmät, ISLAB

      Sansia Oy suunnittelee mikrobiologian nukleiinihappo-osoitusmenetelmien hankintaa ja pyytää toimittajilta tietoa ja kommentteja markkinakartoitusta varten. Toimittajat voivat antaa palautetta tutustumalla liitteeseen "Saate tietopyyntöön", täydentämällä liitteen "Tietopyynnön kysymykset" ja lataamalla muita kommentteja sekä tuote-esitteitä.

      PlanningOct 8, 2026
      Oct 30, 2026(20 days)
    • HUS-yhtymä

      REQUEST FOR INFORMATION: HUS 364-2026 Osseointegrated implant systems

      HUS Group is planning the procurement of osseointegrated implant systems for patients with upper and/or lower limb loss, including intramedullary osseointegrated implants, fixation components, prosthetic attachment systems, surgical instruments, and related digital solutions and services. Suppliers are invited to provide information on their products, clinical evidence, regulatory compliance, and support services by submitting responses electronically to kilpailutus.kirurgia@hus.fi. HUS procurement may also invite selected suppliers to participate in a market dialogue meeting via Microsoft Teams to gather further information.

      PlanningAug 13, 2026
      Dec 13, 2026(64 days)